Inventor
MOUSSA ADEL M
US30 patents
⚠️ This page may combine multiple inventors who share the name “MOUSSA ADEL M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDENIX PHARMACEUTICALS INC
7 patentsUS9211300B2Dec 15, 2015
4′-fluoro nucleosides for the treatment of HCV
IDENIX PHARMACEUTICALS INC66 citations97
US9109001B2Aug 18, 2015
3′,5′-cyclic phosphoramidate prodrugs for HCV infection
IDENIX PHARMACEUTICALS INC60 citations97
US9339541B2May 17, 2016
Thiophosphate nucleosides for the treatment of HCV
IDENIX PHARMACEUTICALS INC36 citations93
US9309275B2Apr 12, 2016
3′-deoxy nucleosides for the treatment of HCV
IDENIX PHARMACEUTICALS INC28 citations93
US9187515B2Nov 17, 2015
2′,4′-fluoro nucleosides for the treatment of HCV
IDENIX PHARMACEUTICALS INC51 citations93
US7598373B2Oct 6, 2009
Process for the production of 2-C-methyl-D-ribonolactone
IDENIX PHARMACEUTICALS INC43 citations87
US7960428B2Jun 14, 2011
Enantiomerically pure phosphoindoles as HIV inhibitors
IDENIX PHARMACEUTICALS INC3 citations59
IDENIX PHARMACEUTICALS LLC
6 patentsUS9192621B2Nov 24, 2015
Esters and malonates of SATE prodrugs
IDENIX PHARMACEUTICALS LLC32 citations93
US10683321B2Jun 16, 2020
4′-or nucleosides for the treatment of HCV
IDENIX PHARMACEUTICALS LLC2 citations72
US10238680B2Mar 26, 2019
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
IDENIX PHARMACEUTICALS LLC0 citations51
US10513534B2Dec 24, 2019
2′-chloro nucleoside analogs for HCV infection
IDENIX PHARMACEUTICALS LLC0 citations50
US10723754B2Jul 28, 2020
2′,4′-bridged nucleosides for HCV infection
IDENIX PHARMACEUTICALS LLC0 citations40
US10717758B2Jul 21, 2020
D-amino acid compounds for liver disease
IDENIX PHARMACEUTICALS LLC0 citations40
CHILDRENS MEDICAL CENTER
3 patentsUS6028103AFeb 22, 2000
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
CHILDRENS MEDICAL CENTER36 citations90
US6800658B2Oct 5, 2004
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
CHILDRENS MEDICAL CENTER3 citations60
US7531573B2May 12, 2009
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
CHILDRENS MEDICAL CENTER0 citations38
JOHNSON MATTHEY PHARMACEUTICAL
3 patentsUS6462221B1Oct 8, 2002
Synthesis of nitroalcohol diastereomers
JOHNSON MATTHEY PHARMACEUTICAL9 citations68
US6752929B1Jun 22, 2004
Methods of separating FTC isomers and derivatives thereof
JOHNSON MATTHEY PHARMACEUTICAL6 citations57
US6541631B1Apr 1, 2003
Methods of separating FTC isomers and derivatives thereof
JOHNSON MATTHEY PHARMACEUTICAL1 citations47
PHARM ECO LAB INC
3 patentsUS6201120B1Mar 13, 2001
Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
PHARM ECO LAB INC3 citations57
US6063921AMay 16, 2000
Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
PHARM ECO LAB INC4 citations57
US6268535B1Jul 31, 2001
Synthesis of 3-aryl-1-indanamines
PHARM ECO LAB INC3 citations54
NUCHEM PHARMACEUTICALS INC
2 patentsUS6534497B1Mar 18, 2003
Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
NUCHEM PHARMACEUTICALS INC3 citations56
US6992079B2Jan 31, 2006
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
NUCHEM PHARMACEUTICALS INC0 citations35